Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Amortizatization of Intangibles (2022 - 2023)

Spruce Biosciences (SPRB) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $66000.0 as the latest value for Q4 2023.

  • Quarterly Amortizatization of Intangibles fell 29.03% to $66000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $66000.0 through Sep 2024, down 90.05% year-over-year, with the annual reading at $636000.0 for FY2023, 4075.0% up from the prior year.
  • Amortizatization of Intangibles for Q4 2023 was $66000.0 at Spruce Biosciences, down from $138000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $249000.0 in Q2 2023, with the low at -$56000.0 in Q1 2022.